Molina Healthcare, Inc. (MOH)
NYSE: MOH · Real-Time Price · USD
147.71
-2.33 (-1.55%)
At close: Mar 5, 2026, 4:00 PM EST
147.71
0.00 (0.00%)
After-hours: Mar 5, 2026, 4:58 PM EST
Molina Healthcare Stock Forecast
Stock Price Forecast
The 12 analysts with 12-month price forecasts for Molina Healthcare stock have an average target of 170.17, with a low estimate of 124 and a high estimate of 330. The average target predicts an increase of 15.21% from the current stock price of 147.71.
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Molina Healthcare stock from 13 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 3 | 3 | 3 | 3 | 2 | 2 |
| Hold | 9 | 9 | 9 | 9 | 10 | 10 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 13 | 13 | 13 | 13 | 13 | 13 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Hold Maintains $158 → $128 | Hold | Maintains | $158 → $128 | -13.34% | Mar 4, 2026 |
| Wells Fargo | Wells Fargo | Buy → Hold Downgrades $208 → $141 | Buy → Hold | Downgrades | $208 → $141 | -4.54% | Feb 20, 2026 |
| Truist Securities | Truist Securities | Hold Maintains $190 → $145 | Hold | Maintains | $190 → $145 | -1.83% | Feb 17, 2026 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $167 → $124 | Hold | Maintains | $167 → $124 | -16.05% | Feb 12, 2026 |
| Barclays | Barclays | Sell Maintains $164 → $133 | Sell | Maintains | $164 → $133 | -9.96% | Feb 10, 2026 |
Financial Forecast
Revenue This Year
45.13B
from 43.56B
Increased by 3.59%
Revenue Next Year
47.97B
from 45.13B
Increased by 6.30%
EPS This Year
7.78
from 8.92
Decreased by -12.82%
EPS Next Year
10.99
from 7.78
Increased by 41.31%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 48.7B | 53.8B | |||
| Avg | 45.1B | 48.0B | |||
| Low | 42.8B | 42.7B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 11.8% | 19.2% | |||
| Avg | 3.6% | 6.3% | |||
| Low | -1.7% | -5.3% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 14.70 | 17.85 | |||
| Avg | 7.78 | 10.99 | |||
| Low | 4.90 | 5.91 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 64.8% | 129.5% | |||
| Avg | -12.8% | 41.3% | |||
| Low | -45.1% | -24.0% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.